Entrepreneur Uses ChatGPT and AlphaFold to Create Experimental mRNA Cancer Vaccine for His Dog

 

Paul Conyngham states that he created custom mRNA vaccines with AI tools such as ChatGPT and AlphaFold to treat his dog suffering of cancer after every other treatment method had failed to prevent the tumour.

Artificial intelligence is also finding its applications in much more areas than in code and automation. Regarding the way the AI tools can be applied in the field of scientific research, in one such example, an Australian technological entrepreneur was reported to have utilized artificial intelligence to engineer an experimental cancer vaccine on his pet dog after the standard treatments were unsuccessful. The case draws attention to the possibility of the increasing role of AI-based tools in personalised medicine or developments in disease research.

Paul Conyngham of Australian news programme Today added, when she was given the sentence, that he had to play his part in her.

In case of failure of conventional management.

It is a story about Australian tech entrepreneur Paul Conyngham and his rescue dog Rosie. In 2019, Conyngham bought the Staffy-Shar Pei mix in an animal shelter. A few years after that, Rosie became ill with cancer of a violent nature. The tumour did not reduce in size despite their undergoing of costly treatment procedures like chemotherapy and surgery.

With few alternatives, Conyngham had a choice to make the unusual way. Using his exposure to machine learning and data analysis, he started research on how to analyse the cancer of Rosie on a genetic basis and how to possibly create a specific treatment.

The application of AI in the analysis of the tumour.

In order to initiate the process, the tumour DNA of Rosie was sequenced by the Ramaciotti Centre of Genomics at the University of New South Wales. The sequencing was approximately 3,000 Australian dollars and enabled him to compare the healthy DNA of the dog with the tumour DNA to find out the presence of harmful mutations.


After that, he relied on the AI chatbot ChatGPT to assist with the organization of the research process and the analysis of the potentially effective treatment plans. The other AI system is AlphaFold created by Google DeepMind, and it aided in predicting the behavior of mutated proteins associated with the cancer. This enabled him to find out possible targets of therapy.

The data was later utilised in collaboration with researchers based at University of New South Wales and other researchers to produce personalised mRNA vaccine specific to stimulate the immune system of Rosie to destroy the cancerous cells.

Promising early results

In December, Rosie was injected with the experimental vaccine in the first instance, with boosters administered later. One of the tumours reduced in size after the treatment according to the researchers that participated in the project, which is an indication that the method is effective.

Conyngham has however indicated that he does not view the treatment as a total cure. Rather, he feels that the vaccine has assisted in increasing the quality of life of Rosie and this could have even increased the time when she will live.

The possible implications of this on cancer research.

According to scientists, the case points to the possible potential of AI and genetic analysis in creating personalised medical therapies. Although this vaccine was developed in a dog, scientists argue that with some time, similar methods can be used to develop personalised treatment against cancer patients in humans.